
Institute of Biotechnology
of the Czech Academy of Sciences

Jakub Rohlena received he Czech Science Foundation President’s Award
The President of the Czech Science Foundation (GACR) together with the Minister for Science, Research and Innovation awarded the five best scientific projects at the 20th anniversary ceremony of the Czech Science Foundation President's Awards yesterday (12 October 2023) at the Martinský Palace. The award recipients from all areas of basic research have contributed to a significant expansion of knowledge in the field and will lead to further applications.

Scientists discover the function of NEUROD1 protein in the development of ...
Scientists from the Institute of Biotechnology (BTU) of the CAS at the Biotechnology and Biomedicine Centre of the Czech Academy of Sciences and Charles University (BIOCEV) and the Institute of Clinical and Experimental Medicine (IKEM) have elucidated the crucial role of the NEUROD1 protein in the development of severe diabetes. MODY6 diabetes is a subtype of diabetes caused by a mutation in the neurogenic differentiation factor 1 (NEUROD1) gene. ...

Gabriela Pavlínková received the Honorary Recognition of the President of ...
For the excellent results of the project "The role of NEUROD1 and ISL1 in the development of inner ear neurons" Gabriela Pavlínková received an honorary recognition from the President of the Grant Agency of the Czech Republic (GAČR) last week.

Researching the way cancer cells communicate brings hope for new treatment
Cancer cells need an immense amount of building material to proliferate. When they run out, they are able to persuade healthy nearby cells to supply them. How they do so is the subject of research done by Kateřina Rohlenová from the Institute of Biotechnology of the CAS: “We already know quite well what happens on the inside of cancer cells. We now want to map what happens in their surroundings. ...

Visit of Nobel Prize winner Professor Gregg L. Semenza
During his stay in the Czech Republic, Nobel Prize winner in Physiology and Medicine Professor Gregg L. Semenza visited IBT at the BIOCEV center. It was the first visit of a Nobel Prize winner in the history of the center and his lecture on "Hypoxia-inducible factors in Physiology and medicine" filled the conference hall to the last seat.

An international team with a Czech scientist will cast light on the secret ...
The most prestigious scientific grant awarded by the European Research Council, the ERC Synergy Grant, goes to the team of Zdenek Lánský from the Institute of Biotechnology of the Czech Academy of Sciences in the BIOCEV center. With French and American colleagues, he will investigate the function of a protein called tubulin, which is significantly involved in the transport of substances inside cells. ...

Functional clustering of surface receptors of human immune cells
A new study focused on the structure and function of natural killer cell surface receptors was recently published in the prestigious journal Nature Communications. The study comes from the research teams of Dr. Ondřej Vaněk from the Department of Biochemistry, Faculty of Science, Charles University, and Dr. Jan Dohnálek from the Institute of Biotechnology of the Czech Academy of Sciences.

Protein named after the mythological goddess Maia plays a key role in the ...
A new protein that plays a key role during sperm-egg adhesion and fusion has been discovered by an international team led by Kateřina Komrsková from the Institute of Biotechnology of the Czech Academy of Sciences at the BIOCEV Centre and the Faculty of Science of Charles University in Prague. The researchers also developed special cell cultures for the “production” of human oocyte proteins. ...

Members of the Scientific Advisory Board of the IBT met to evaluate the ...
The aim of the two-day meeting held on June 2-3 was to evaluate the research results and plans for further activities of six research laboratories, i.e. half of the Institute of Biotechnology operating in the BIOCEV center. Members of the Scientific Advisory Board of the Institute of Biotechnology of the CAS (SAB) and two external members of the IBT Board met for this purpose for the first time since the establishment of the SAB in 2021.